| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Longitude Capital Partners Iv, LLC serves as a 10% Owner at LXEO and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 4 buys and 0 sells. Those positions are worth an estimated $65.5M at current prices.
Historically, Longitude Capital Partners Iv, LLC's trades have earned a middling insider score of 63/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +13.3%.
The biggest single holding is VERA (~$52.9M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 2,956,708 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | LXEO Lexeo Therapeutics, Inc. | 10% Owner | Buy | 454,545 | $11.00 | $4,999,995.00 | +21.5% | +61.6% | -21.6% | |
| Feb 6, 2023 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 1,714,285 | $7.00 | $11,999,995.00 | New | +8.5% | +445.9% | |
| Feb 10, 2022 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +10.8% | -14.9% | -58.0% | |
| May 18, 2021 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +41.6% | +37.7% | +32.9% |